Key terms

About RGEN

Repligen Corp. is a global life sciences company, which engages in providing bioprocessing technologies and solutions used in the process of manufacturing biological drugs. It operates through the North America. Europe, and Asia Pacific Region or Other geographical segments. The company was founded by Alexander G. Rich and Paul R. Schimmel in May 1981 and is headquartered in Waltham, MA.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest RGEN news

Yesterday 4:55am ET Repligen participates in a conference call with JPMorgan by TipRanks May 06 5:01pm ET Repligen participates in a conference call with JPMorgan by TipRanks May 03 7:42am ET Analysts Offer Insights on Healthcare Companies: Biomea Fusion (BMEA), Repligen (RGEN) and Agenus (AGEN) by TipRanks May 03 7:42am ET Benchmark Co. Sticks to Their Hold Rating for Repligen (RGEN) by TipRanks May 02 8:33am ET Repligen (RGEN) Receives a Buy from Stifel Nicolaus by TipRanks May 01 7:32am ET Repligen reports Q1 adjusted EPS 28c, consensus 30c by TipRanks Apr 30 9:49pm ET Repligen (RGEN) Gets a Buy from RBC Capital by TipRanks Apr 19 9:15am ET Positive Report for Repligen (RGEN) from Craig-Hallum by TipRanks Apr 08 9:45pm ET RBC Capital Remains a Buy on Repligen (RGEN) by TipRanks Mar 25 2:05pm ET Ingersoll-Rand’s Dover deal not a threat to bioprocessing space, says KeyBanc by TipRanks Mar 19 7:52am ET Repligen Corp Announces Board Appointment and Compensation Plan by TipRanks Mar 19 7:35am ET Repligen appoints Pax to board of directors by TipRanks Feb 26 12:10am ET Analysts Have Conflicting Sentiments on These Healthcare Companies: Immuneering (IMRX), Halozyme (HALO) and Repligen (RGEN) by TipRanks Feb 23 9:14am ET Repligen price target raised to $225 from $175 at Craig-Hallum by TipRanks Feb 22 8:58am ET Repligen price target raised to $207 from $165 at Stifel by TipRanks Feb 22 8:17am ET Repligen (RGEN) Receives a Buy from Stifel Nicolaus by TipRanks Feb 22 7:31am ET Repligen (RGEN) Receives a Buy from RBC Capital by TipRanks Feb 21 7:34am ET Repligen reports Q4 adjusted EPS 33c, consensus 33c by TipRanks Feb 20 8:39am ET Repligen (RGEN) Gets a Buy from Craig-Hallum by TipRanks Feb 15 8:46am ET Craig-Hallum Remains a Buy on Repligen (RGEN) by TipRanks Feb 15 6:44am ET Repligen price target raised to $220 from $210 at KeyBanc by TipRanks

No recent press releases are available for RGEN

RGEN Financials

1-year income & revenue

Key terms

RGEN Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

RGEN Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms

Latest investing news

Bruce Garelick was found guilty of insider trading
John Minchillo/AP
Investor found guilty in Trump Media insider trading case
People walk toward an entrance to Disneyland in Anaheim, California on April 24, 2023.
Mario Tama/Getty Images/File
Americans are shopping less but they’re still spending on flights, hotels and Disneyland
Scaffolding and construction netting near an apartment building in New York, US, on Wednesday, Oct. 11, 2023. Monthly fees and expenses for inspections, insurance and climate-friendly upgrades are squeezing residents of the city's many co-op and condo buildings. Photographer: Michael Nagle/Bloomberg
Michael Nagle/Bloomberg/Getty Images
For US renters, the chance of owning a home is going from bad to worse
Close-up detail of the Disney+ app icon on an Apple iPhone 12 Pro smartphone screen, on November 11, 2020. (Photo by Phil Barker/Future Publishing via Getty Images)
Phil Barker/Future Publishing/Getty Images
Disney just had its worst day in a year and a half